Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 40 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 40 IN PLASTIC CONTAINER.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 40% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose is a monosaccharide that serves as a substrate for cellular energy production via glycolysis and the citric acid cycle. It increases blood glucose levels, providing an immediate source of calories and carbohydrate for patients with hypoglycemia or caloric needs.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Adults: 50 mL (20 g dextrose) intravenously as a single dose for hypoglycemia; may repeat if needed. For hyperkalemia with insulin: 25 g (62.5 mL) IV with 10 units regular insulin.
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
30-60 minutes; clinical context: rapid redistribution and metabolism limit hyperglycemic effect, but in glucose-6-phosphatase deficiency or hepatic impairment, half-life may extend to 2-4 hours.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Dextrose is completely metabolized to carbon dioxide and water; less than 5% is excreted unchanged in urine. Renal excretion accounts for <5% of elimination; biliary/fecal elimination is negligible.
Category C
Category C
IV Fluid
IV Fluid